VTGM buiten de apotheek en toediening medicatie Module 3 Risk-of-bias-tabel
|
Study reference (first author, publication year) |
Was the allocation sequence adequately generated? Definitely yes Probably yes Probably no Definitely no |
Was the allocation adequately concealed? Definitely yes Probably yes Probably no Definitely no |
Blinding: Was knowledge of the allocated interventions adequately prevented? Were patients blinded? Were healthcare providers blinded? Were data collectors blinded? Were outcome assessors blinded? Were data analysts blinded? Definitely yes Probably yes Probably no Definitely no |
Was loss to follow-up (missing outcome data) infrequent? Definitely yes Probably yes Probably no Definitely no |
Are reports of the study free of selective outcome reporting? Definitely yes Probably yes Probably no Definitely no |
Was the study apparently free of other problems that could put it at a risk of bias? Definitely yes Probably yes Probably no Definitely no |
Overall risk of bias If applicable/necessary, per outcome measure LOW Some concerns HIGH |
|
Siddiqui, 2014 |
Probably yes; Reason: unclear, but assumed yes |
Definitely yes; Reason: sealed envelope |
Partially definitely yes; partially no (patients, anaesthesiologists) Reason: Open-label trial (patients and health care providers not blinded), outcome assessors blinded (blinding of data collectors and analysts not reported). Did not influence the outcome. |
Definitely yes; Reason: Loss to follow-up was infrequent in intervention and control group |
Definitely yes; Reason: All relevant outcomes were reported |
Definitely yes; Reason: No other problems noted |
LOW |
|
Siddiqui, 2017 |
Definitely yes; Reason: computer generated |
Definitely yes; Reason: sealed envelope |
Partially definitely yes; partially no (patients, anaesthesiologists) Reason: Open-label trial (patients and health care providers not blinded), outcome assessors blinded (blinding of data collectors and analysts not reported). Did not influence the outcome. |
Definitely yes; Reason: Loss to follow-up was infrequent in intervention and control group |
Definitely yes; Reason: All relevant outcomes were reported |
Definitely yes; Reason: No other problems noted |
LOW |
|
Onofrei, 2017 |
Unclear Reason: unclear |
Unclear Reason: unclear |
Partially definitely yes; partially no (patients, anaesthesiologists) Reason: Open-label trial (patients and health care providers not blinded), outcome assessors blinded (blinding of data collectors and analysts not reported). Did not influence the outcome. |
Definitely yes; Reason: Loss to follow-up was infrequent in intervention and control group |
Definitely yes; Reason: All relevant outcomes were reported |
Definitely yes; Reason: No other problems noted |
LOW |